YSB (HKG:9885) granted over 2.5 million award shares to 415 employees on Tuesday under a 2023 incentive scheme, according to a same-day Hong Kong bourse filing.
The shares represent 0.37% of the pharmaceutical retailer's issued share capital.
The firm now has 45.5 million shares available for future grant under the scheme mandate limit and 1.1 million shares available under the service provider sublimit.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.